Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Uncover various ways to access cash for debt repayment that can streamline your path to financial stability. Explore your options today.
22,799 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Best Buy lines up a roughly 5% yield with solid cash flow, reinforcing dividend safety: this big-box for income-focus...
As UnitedHealth gears up for its July 16 results, traders focus on pricing power and rising cash flow as the main rea...
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
In May, walmart stock dropped 12% despite solid earnings. This in-depth look breaks down the drivers behind the decli...
Two very different tech plays collide in 2026: Innodata edges into AI data preparation, while Workiva anchors large e...
As year-to-date markets swing, Disney and PayPal stand out as potential rebound plays. This article weighs dividends,...
Greg Abel is redefining Berkshire Hathaway’s course with three bold moves: pruning a laggard investment, expanding ho...
DLocal faces a pivotal year as Q1 2026 results shape the path to 2026 earnings. This guide breaks down the key metric...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...